Bleeding Disorders
From the Journals
Cardiovascular problems already apparent in children with hemophilia A
...
News
FDA approves recombinant treatment for hemophilia A or B with inhibitors
The new treatment is made using milk from transgenic rabbits.
Conference Coverage
Early results with ‘optimized’ gene therapy in hemophilia A
Conference Coverage
Gene therapy effective in hemophilia B patients with neutralizing antibodies
Conference Coverage
Fear drives activity changes in hemophilia patients
From the Journals
Occult HCV infection is correlated to unfavorable genotypes in hemophilia patients
Unfavorable interferon gentoypes were correlated to occult HCV infection in paitents with hemophilia.
From the Journals
Turoctocog alfa prevented, treated bleeds in previously untreated pediatric patients with severe hemophilia A
In guardian 4, the first trial in its series to evaluate previously untreated patients, recombinant factor VIII was well tolerated, and...
Conference Coverage
Age, sex, and other factors linked to risk of intracranial hemorrhage in ITP
ORLANDO – Being older, male, and not having private insurance were some of the risk factors for intracranial hemorrhage among patients with immune...
Conference Coverage
Phase 2 studies show potential of FcRn blockade in primary ITP
ORLANDO – The results support continued investigation in phase 3 trial for rozanolixizumab and efgartigimod, according to investigators.
Conference Coverage
Think twice: Choosing Wisely recommendations on testing to avoid in pediatric hematology
ORLANDO – The list, which was released by ASH and the American Society of Pediatric Hematology/Oncology, includes five unnecessary tests or...
Conference Coverage
Best practice alerts really can work
SAN ANTONIO – A majority of alerts triggered by red blood cell orders were overridden, but for sound clinical reasons, investigators found.